Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 3:59 PM
5.98
1.36%
After-hours: Aug 15, 2025, 04:00 PM EDT

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.77M -2.34M -3.2M -3.23M -2.88M -3.2M -2.22M -1.81M -1.73M -2.28M -1.71M -2.45M -2.73M -2.79M -2.55M -1.71M -1.33M -2.26M
Interest Income
71.64K 36.22K 49.35K 52.5K 54.64K 69.3K 85.86K 92.77K 31.05K 37.54K 42.09K 21.49K n/a n/a n/a n/a n/a n/a
Pretax Income
-1.7M -2.3M -3.15M -3.17M -2.83M -3.13M -2.13M -1.72M -1.7M -2.24M -1.67M -2.42M -2.73M -2.79M -2.55M -1.71M -1.33M -2.31M
Net Income
-1.7M -2.3M -3.15M -3.17M -2.83M -3.13M -2.13M -1.72M -1.7M -2.24M -1.58M -2.38M -2.73M -2.79M -2.55M -1.71M -1.33M -2.31M
Selling & General & Admin
1.15M 1.06M 1.01M 824.29K 874.64K 1.6M 1.08M 909K 893.48K 1.08M 822.33K 892.78K 1.12M 1.19M 1.44M 912.49K 462.77K 1.58M
Research & Development
617.84K 1.28M 2.19M 2.4M 2.01M 1.6M 1.14M 902.98K 838.93K 1.19M 889.36K 1.55M 1.61M 1.6M 1.11M 799.78K 867.2K 680.59K
Other Expenses
n/a n/a n/a 706.00 360.00 n/a n/a 23.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.77M 2.34M 3.2M 3.23M 2.88M 3.2M 2.22M 1.81M 1.73M 2.28M 1.71M 2.45M 2.73M 2.79M 2.55M 1.71M 1.33M 2.26M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 45.57M 651.00 1.82K 43.13K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 2.34M 3.2M 3.23M 2.88M 3.2M 2.22M 1.81M 1.73M 2.28M 1.71M 2.45M 2.73M 2.79M 2.55M 1.71M 1.33M 2.26M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -2.22K -1.81K -1.73K n/a -84.17K -42.97K n/a n/a -45.57M -81 -81 -81
Shares Outstanding (Basic)
1.03M 515.5K 155.5K 155.5K 67.66K 44.41K 393.1K 21.26K 270.5K 6.57K 77.01K 5.12K 69.97K 52.05K 835.2K 31.13K 46.97K 52.05K
Shares Outstanding (Diluted)
1.03M 515.5K 155.5K 155.5K 67.66K 44.41K 393.1K 21.26K 18.03K 6.57K 77.01K 5.12K 4.66K 52.2K 835.2K 31.13K 46.97K 52.05K
EPS (Basic)
-1.66 -4.47 -20.4 -20.4 -41.82 -70.58 -5.4 -80.86 -94.3 -340.8 -20.6 -474 -585 -802.5 -3.1 -2.06K -425.3 -664.2
EPS (Diluted)
-1.66 -4.47 -20.4 -20.4 -41.82 -70.58 -5.4 -80.86 -94.3 -340.8 -20.6 -474 -585 -802.5 -3.1 -2.06K -425.3 -664.2
EBITDA
-1.77M -2.34M -3.15M -3.23M -2.88M n/a -2.13M -1.81M -1.73M -2.28M -1.71M -2.45M -2.73M -2.79M -2.55M -1.71M -1.33M -2.26M
EBIT
n/a -2.34M -3.15M -3.23M -2.88M -3.2M -2.13M -1.81M -1.7M -2.28M -1.67M -2.45M -2.73M -2.79M -2.55M -1.71M -1.33M -2.26M
Depreciation & Amortization
n/a n/a n/a n/a 2.88M 3.2M n/a 1.81M 1.73M n/a -42.97K 2.45M 2.73M 2.79M 81.00 81.00 81.00 81.00